Clinical Trial Update: Survival According to the Feeding Artery Obliteration by Chemoembolization for Unresectable Hepatocellular Carcinoma [NA]

View source ↗

Summary

ClinicalTrials.gov update on survival related to feeding artery obliteration by transarterial chemoembolization for unresectable hepatocellular carcinoma. The c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Hallym University Medical Center | Conditions: Hepatocellular Carcinoma, Transarterial Chemoembolization | NA | Status: UNKNOWN